These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

78 related items for PubMed ID: 1069606

  • 1. Cytotoxic effects of 1-beta-D-arabinofuranosylcytosine and 6-thioguanine in vitro on granulocytic progenitor cells.
    Greenberg PL, VanKersen I, Mosny S.
    Cancer Res; 1976 Dec; 36(12):4412-7. PubMed ID: 1069606
    [Abstract] [Full Text] [Related]

  • 2. Cytotoxic effects of interferon in vitro on granulocytic progenitor cells.
    Greenberg PL, Mosny SA.
    Cancer Res; 1977 Jun; 37(6):1794-9. PubMed ID: 870186
    [Abstract] [Full Text] [Related]

  • 3. The effect of a prolonged in vitro exposure to 1-beta-D arabinofuranosylcytosine and deoxycytidine on the survival of normal (CFU-GM) and leukemic (L-CFU) human myeloid progenitor cells in suspension culture.
    Grant S, Bhalla K, Arlin Z, Howe CW.
    Exp Hematol; 1990 Jan; 18(1):41-8. PubMed ID: 2298268
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. The enhanced cytotoxicity of combinations of 1-beta-D-arabinofuranosylcytosine and methotrexate.
    Edelstein M, Vietti T, Valeriote F.
    Cancer Res; 1975 Jun; 35(6):1555-8. PubMed ID: 1131822
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Combined effect of cytosine arabinoside and thiopurines.
    Valeriote F, Vietti T, Edelstein M.
    Cancer Treat Rep; 1976 Dec; 60(12):1925-34. PubMed ID: 1026347
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [An in vitro chemotherapy sensitivity test on leukemic colony-forming cells (L-CFU) and its clinical evaluation].
    Moriyama Y, Urushiyama M, Hirosawa H, Koyama S, Takai K, Fujiwara M, Kishi K, Takahashi M, Sakai C, Sanada M, Shibata A.
    Gan To Kagaku Ryoho; 1982 Oct; 9(10):1749-54. PubMed ID: 7184371
    [Abstract] [Full Text] [Related]

  • 14. Schedule-dependent synergy and antagonism between high-dose 1-beta-D-arabinofuranosylcytosine and asparaginase in the L5178Y murine leukemia.
    Schwartz SA, Morgenstern B, Capizzi RL.
    Cancer Res; 1982 Jun; 42(6):2191-7. PubMed ID: 7074600
    [Abstract] [Full Text] [Related]

  • 15. Cystathionine-beta-synthase cDNA transfection alters the sensitivity and metabolism of 1-beta-D-arabinofuranosylcytosine in CCRF-CEM leukemia cells in vitro and in vivo: a model of leukemia in Down syndrome.
    Taub JW, Huang X, Ge Y, Dutcher JA, Stout ML, Mohammad RM, Ravindranath Y, Matherly LH.
    Cancer Res; 2000 Nov 15; 60(22):6421-6. PubMed ID: 11103808
    [Abstract] [Full Text] [Related]

  • 16. Effect of arabinosyl cytosine on granulopoietic colony formation by marrow cells from leukemic and non-leukemic patients.
    Niho Y, Till JE, McCulloch EA.
    Exp Hematol; 1976 Mar 15; 4(2):63-9. PubMed ID: 1063075
    [Abstract] [Full Text] [Related]

  • 17. Direct relationship of marrow cell growth and 1-beta-D-arabinofuranosylcytosine metabolism.
    Karp JE, Donehower RC, Dole GB, Burke PJ.
    Cancer Res; 1984 Nov 15; 44(11):5046-50. PubMed ID: 6488163
    [Abstract] [Full Text] [Related]

  • 18. Synergistic inhibition in vivo of bone marrow myeloid progenitors by myelosuppressive chemokines and chemokine-accelerated recovery of progenitors after treatment of mice with Ara-C.
    Broxmeyer HE, Pelus LM, Kim CH, Hangoc G, Cooper S, Hromas R.
    Exp Hematol; 2006 Aug 15; 34(8):1069-77. PubMed ID: 16863913
    [Abstract] [Full Text] [Related]

  • 19. In vitro pharmacodynamics of 1-beta-D-arabinofuranosylcytosine: synergy of antitumor activity with cis-diamminedichloroplatinum(II).
    Kern DH, Morgan CR, Hildebrand-Zanki SU.
    Cancer Res; 1988 Jan 01; 48(1):117-21. PubMed ID: 3334986
    [Abstract] [Full Text] [Related]

  • 20. GM-CSF enhances sensitivity of leukemic clonogenic cells to long-term low dose cytosine arabinoside with sparing of the normal clonogenic cells.
    De Witte T, Muus P, Haanen C, Van der Lely N, Koekman E, Van der Locht A, Blankenborg G, Wessels J.
    Behring Inst Mitt; 1988 Aug 01; (83):301-7. PubMed ID: 3071344
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.